Cme Group Stock Performance
| CME Stock | USD 267.94 5.43 2.07% |
The firm shows a Beta (market volatility) of -0.45, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning CME are expected to decrease at a much lower rate. During the bear market, CME is likely to outperform the market. At this point, CME Group has a negative expected return of -0.0255%. Please make sure to confirm CME's potential upside, day median price, and the relationship between the treynor ratio and accumulation distribution , to decide if CME Group performance from the past will be repeated in the future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days CME Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, CME is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| CME dividend paid on 25th of September 2025 | 09/25/2025 |
| Begin Period Cash Flow | 93.1 B | |
| Total Cashflows From Investing Activities | -82.6 M |
CME Relative Risk vs. Return Landscape
If you would invest 27,333 in CME Group on July 22, 2025 and sell it today you would lose (539.00) from holding CME Group or give up 1.97% of portfolio value over 90 days. CME Group is generating negative expected returns assuming volatility of 1.0681% on return distribution over 90 days investment horizon. In other words, 9% of stocks are less volatile than CME, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
CME Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CME's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CME Group, and traders can use it to determine the average amount a CME's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0239
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CME |
Estimated Market Risk
| 1.07 actual daily | 9 91% of assets are more volatile |
Expected Return
| -0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CME is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CME by adding CME to a well-diversified portfolio.
CME Fundamentals Growth
CME Stock prices reflect investors' perceptions of the future prospects and financial health of CME, and CME fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CME Stock performance.
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0174 | ||||
| Profit Margin | 0.59 % | ||||
| Operating Margin | 0.67 % | ||||
| Current Valuation | 96.98 B | ||||
| Shares Outstanding | 360.38 M | ||||
| Price To Earning | 32.83 X | ||||
| Price To Book | 3.45 X | ||||
| Price To Sales | 15.01 X | ||||
| Revenue | 6.13 B | ||||
| EBITDA | 5.04 B | ||||
| Cash And Equivalents | 2.22 B | ||||
| Cash Per Share | 6.19 X | ||||
| Total Debt | 3.43 B | ||||
| Debt To Equity | 0.12 % | ||||
| Book Value Per Share | 77.13 X | ||||
| Cash Flow From Operations | 3.69 B | ||||
| Earnings Per Share | 10.34 X | ||||
| Total Asset | 137.45 B | ||||
| Retained Earnings | 4.19 B | ||||
| Current Asset | 37.9 B | ||||
| Current Liabilities | 36.82 B | ||||
About CME Performance
By analyzing CME's fundamental ratios, stakeholders can gain valuable insights into CME's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CME has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CME has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. CME operates under Financial Data Stock Exchanges classification in the United States and is traded on NASDAQ Exchange. It employs 3480 people.Things to note about CME Group performance evaluation
Checking the ongoing alerts about CME for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CME Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CME Group generated a negative expected return over the last 90 days | |
| Over 91.0% of the company shares are held by institutions such as insurance companies | |
| On 25th of September 2025 CME paid $ 1.25 per share dividend to its current shareholders |
- Analyzing CME's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CME's stock is overvalued or undervalued compared to its peers.
- Examining CME's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CME's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CME's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CME's stock. These opinions can provide insight into CME's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CME Stock analysis
When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |